In a study published on May 12, 2026, in the medical journal The Lancet, an international team of researchers and health professionals formally announced the renaming of the condition to polyendocrine metabolic ovarian syndrome, or PMOS. Dr. Melanie Cree, a pediatric endocrinologist at the University of Colorado Anschutz, was part of the team behind the renaming.
CU Anschutz
Administrative Pavilion
13123 E. 16th Ave.
B065
Aurora, CO 80045